Practice guideline update summary: Corticosteroid treatment of Duchenne muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology

Neurology
David GlossMaryam Oskoui

Abstract

To update the 2005 American Academy of Neurology (AAN) guideline on corticosteroid treatment of Duchenne muscular dystrophy (DMD). We systematically reviewed the literature from January 2004 to July 2014 using the AAN classification scheme for therapeutic articles and predicated recommendations on the strength of the evidence. Thirty-four studies met inclusion criteria. In children with DMD, prednisone should be offered for improving strength (Level B) and pulmonary function (Level B). Prednisone may be offered for improving timed motor function (Level C), reducing the need for scoliosis surgery (Level C), and delaying cardiomyopathy onset by 18 years of age (Level C). Deflazacort may be offered for improving strength and timed motor function and delaying age at loss of ambulation by 1.4-2.5 years (Level C). Deflazacort may be offered for improving pulmonary function, reducing the need for scoliosis surgery, delaying cardiomyopathy onset, and increasing survival at 5-15 years of follow-up (Level C for each). Deflazacort and prednisone may be equivalent in improving motor function (Level C). Prednisone may be associated with greater weight gain in the first years of treatment than deflazacort (Level C). Deflazacort may be associ...Continue Reading

Associated Clinical Trials

Aug 13, 2019·Senda Ajroud-Driss

References

Jan 1, 1991·Neuromuscular Disorders : NMD·L E MesaD Flores
Jun 15, 1989·The New England Journal of Medicine·J R MendellJ Florence
May 1, 1995·Neuromuscular Disorders : NMD·E Bäckman, K G Henriksson
Apr 1, 1994·Muscle & Nerve·C AngeliniC Costa
Jan 10, 2001·The Journal of Pediatrics·W D BiggarC A Steele
Mar 5, 2004·The Journal of Bone and Joint Surgery. American Volume·Benjamin A AlmanW Douglas Biggar
Jul 27, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·O YilmazH Topaloğlu
Sep 1, 2004·Neuromuscular Disorders : NMD·W D BiggarG Nigro
Jan 12, 2005·Archives of Neurology·Ernesto A C BeenakkerJohannes H Van der Hoeven
Jul 2, 2005·Pediatric Cardiology·L W MarkhamL H Cripe
Oct 26, 2005·American Journal of Physical Medicine & Rehabilitation·Birol BalabanTerri Carry
May 5, 2006·Current Opinion in Critical Care·Michel Slama, Julien Maizel
Jun 21, 2006·Journal of Neurology·Sunil PradhanUttam Singh
Jan 30, 2007·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·M KinaliF Muntoni
Apr 15, 2008·European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society·Sophie MavrogeniDennis V Cokkinos
Apr 26, 2008·Neuromuscular Disorders : NMD·Larry W MarkhamLinda H Cripe
Jun 1, 2001·Journal of Clinical Neuromuscular Disease·U ScharaW Mortier
May 12, 2010·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·M L BianchiR Cottafava
Jul 22, 2010·American Journal of Physical Medicine & Rehabilitation·John R BachBilal Saulat
Dec 20, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Valeria RicottiUNKNOWN NorthStar Clinical Network
Jan 29, 2013·Journal of the American College of Cardiology·Gernot SchramPaul Khairy
Mar 14, 2013·Muscle & Nerve·Robert C GriggsKate Bushby
Jun 21, 2013·The Journal of Bone and Joint Surgery. American Volume·David E LebelBenjamin A Alman
Jul 23, 2013·The Journal of Pediatrics·Brent J BarberChristopher Cunniff

❮ Previous
Next ❯

Citations

Apr 27, 2016·Brain & Development·Masahide GotoIkuya Nonaka
Jul 12, 2016·Pediatric Neurology Briefs·Vamshi K Rao
Aug 21, 2016·Neuromuscular Disorders : NMD·Chet R VillaJohn L Jefferies
May 21, 2017·Skeletal Muscle·Joe N Kornegay
Mar 21, 2018·Regenerative Medicine·Lauren A JevonsRahul S Tare
Oct 11, 2017·Developmental Medicine and Child Neurology·Audrey SchreiberUNKNOWN MFM DMD Corticosteroids Group
Nov 11, 2017·Journal of Neuromuscular Diseases·Zaïda KoeksHanns Lochmüller
Jul 3, 2017·Heart·Domenico D'AmarioFilippo Crea
Feb 15, 2018·Muscle & Nerve·Raphael Henrique Déa CirinoClaudio Leinig Pereira da Cunha
Sep 27, 2018·American Journal of Medical Genetics. Part a·Molly M LambUNKNOWN Muscular Dystrophy Surveillance, Research, and Tracking Network (MD STARnet)
Feb 26, 2019·Journal of Clinical Neuromuscular Disease·David Lacomis, Hoda Z Abdel-Hamid
Jul 18, 2019·Expert Opinion on Pharmacotherapy·Alexandra ClayDavid R Lynch
Dec 6, 2019·International Journal of Molecular Sciences·Libero VitielloMarcella Canton
Oct 11, 2019·Muscle & Nerve·Craig M McDonaldUNKNOWN ACT DMD Study Group and the Tadalafil DMD Study Group
Feb 6, 2020·The Annals of Pharmacotherapy·Mary ByloDinesh Yogaratnam
Mar 7, 2020·Expert Opinion on Pharmacotherapy·Sharon M GragesDaniel J Berlau
May 21, 2020·Journal of Clinical Pharmacology·Xiaonan LiWilliam J Jusko
Oct 1, 2019·Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association·Elizabeth WilliamsonTodd Daniel
Sep 5, 2020·Pediatric Pulmonology·Nicolas J Abreu, Megan A Waldrop
Jan 18, 2017·Annals of Clinical and Translational Neurology·Lasya GaurAmi Mankodi
Aug 17, 2017·Arquivos de neuro-psiquiatria·Alexandra P Q C AraujoEdmar Zanoteli
Sep 15, 2018·Journal of Physical Therapy Science·Hitomi NishizawaAkinori Nakamura
Mar 12, 2019·SAGE Open Medicine·Kristin M ConwayUNKNOWN Muscular Dystrophy Surveillance, Tracking and Research Network (MD STARnet)
May 6, 2016·The Cochrane Database of Systematic Reviews·Emma MatthewsAdnan Y Manzur
Jun 28, 2017·Indian Journal of Pediatrics·Renu Suthar, Naveen Sankhyan
Aug 2, 2018·Arquivos de neuro-psiquiatria·Alexandra P Q C AraujoEdna Fátima Reis
Jul 29, 2020·Biology Open·Janelle M SpinazzolaLouis M Kunkel
May 28, 2019·Journal of Pharmacokinetics and Pharmacodynamics·Daniela J ConradoUNKNOWN Duchenne Muscular Dystrophy Regulatory Science Consortium (D-RSC)
Mar 25, 2019·World Journal of Pediatrics : WJP·Qing KeMichele A Gatheridge
Mar 27, 2020·Scientific Reports·Andrea Cerquone PerpetuiniGianni Cesareni
Apr 29, 2020·Annals of Clinical and Translational Neurology·Luca BelloElena Pegoraro
Jun 25, 2018·Current Treatment Options in Neurology·Megan Crone, Jean K Mah
Oct 20, 2020·PloS One·Sarah R RiveraKatherine D Mathews

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.